An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications
Clinical trial NCT04322188 · COMPLETED
Trial details
- NCT number
- NCT04322188
- Sponsor
- A.O. Ospedale Papa Giovanni XXIII
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-19
- Primary completion
- 2020-05-08
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.